Usefulness of measurement of glucose and glycosylated hemoglobin levels in patients with acute coronary syndrome as number predictors of stenotic coronary arteries shown in coronary arteriography;Przydatność pomiaru stȩżenia glukozy i hemoglobiny glikowanej u pacjentów z ostrym zespołem wieńcowym jako predyktorów liczby zajȩtych naczyń uwidocznionych w badaniu koronarograficznym

Polski Merkuriusz Lekarski

Volumn 20, Issue 117, 2006, Pages 270-273

  Markuszewski, Leszek ^a   Bodalska, Joanna ^a   Kamiński, Grzegorz ^b,c   Kuberska Kȩdzierska, Małgorzata ^b,c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

^c CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF NATIONAL DEFENSE   (Poland)

Author keywords

Acute coronary syndrome; Coronary arteries; Coronary heart disease; Diabetes mellitus t.2; Glycosylated haemoglobin

Indexed keywords

C REACTIVE PROTEIN; CREATINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; UREA;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROGNOSIS; WAIST HIP RATIO;

ACUTE DISEASE; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DIABETES COMPLICATIONS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 33645669689     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Beckman J.A., Creager M.A., Libby P.: Diabetes and atherosclerosis- Epidemiology, patophysiology and management. JAMA 2002, 287, 2570-2581.
2. Continho M., Gerstein H.C., Wang Y., Ynsuf S.: The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12,4 years. Diabetes Care, 1999, 22, 233-240.
3. Davies M. J.: The pathophysiology of acute coronary syndromes. Heart, 200, 83, 361-366.
4. Emily B. Levitan i wsp.: Is nondiabetic hyperglycaemia a risk factor for cardiovascular disease? Arch. Intern. Med., 2004, 164, 2147.
5. Foo K., et al.: A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart, 2003, 89, 512-516.
6. Goraya T.Y., Leibson C.I., Palumbo P.J. i wsp.: Coronary atherosclerosis in diabetes mellitus. A population-based autopsy study. J. Am. Coll. Cardiol., 2002, 40, 946-953.
7. Kay-Tee Knaw, Wareham N., Bingham S. et al.: Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in adults: The European Prospective Investigation into Cancer in Norfolk. Annals of Internal Medicine, 2004, 141, 413-421.
8. Maffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laaksoo M.: Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N. Engl. J. Med., 1998, 339, 229-234.
9. Mak K.H., Moliterno D.J., Granger C.B. et al.: Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO I investigators. Global utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J. Am. Coll. Cardiol., 1997, 30, 171-179.
10. Piche M.E., Arcand-Bosse J.F., Despres J.P., Perusse L., Lemieux S., Weisnagel S.J.: What is a normal glucose value? Diabetes Care, 2004, 27, 10, 2470-2477.
11. Ryan T.J., Bauman W.B. Kennedy J.W.: Guidelines for percutaneous transluminal coronary angioplasty: a report of the American Heart Association/ American College of Cardiology Task Force on assessment of dignostic and therapeutic cardiovascular procedures. Circulation, 1993, 6, 2987-3006.
12. Sala J. et al.: Short-term mortality of myocardial infarction patients with diabetes of hyperglycemic during admission. J. Epidemiol. Commun. Health, 2002, 56, 707-712.
13. Singer D.E., Moulton A.W., Nathan D.M.: Diabetic myocardial infarction: interaction of diabetes with other preinfarction risk factors. Diabetes, 1989, 38, 350-357.
14. Standards of medical care in diabetes. American Diabetes Association Diabetes Care, 2004, 27(supl. 1), 15-35.
15. Terenz A., et al.: Myocardial infarction and prevalence of diabetes mellitus: is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur. Heart J., 2001, 22, 1102-1110.
16. The DECODE study group on behalf of the European Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet, 1999, 354, 617-621.
17. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonyloureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33). Lancet, 1998, 352, 837-853.
18. Wahab N.N., et al.: Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J. Am. Coll. Cardiol., 2002, 40, 1748-1754.
19. World Health Organisation. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Czȩsć 1: Report of a WHO Consultation: Diagnosis and Classification of Diabetes Mellitus. World Health Organisation, Geneva, 1999.